Remembering Nobel Laureate Sir James Fraser Stoddart
A tribute to Sir James Stoddart, a towering figure in the field of chemistry and molecular machines, who passed on 30 December 2024 at the age of 82.
Showcasing the next generation of AMR researchers
PhD students and early career researchers showcase the latest advancements in antimicrobial research
Imperial spinout Siftr Bio aims to improve precision of ADC cancer drugs
A new Imperial spinout aims to improve the performance of an emerging class of cancer treatments known as antibody-drug conjugates or ADCs.
It’s unusual that you shared negative data, spinout told, pre £90m raise
Honesty is the best policy, says Myricx's CEO, who used authentic relationships with investors to help the biotech win major funding after a pivot.
Meet the Imperial experts fighting bacterial resistance through innovation
Professor Shiranee Sriskandan and Dr Andrew Edwards shed light on the vital work of Imperial’s Centre for Bacterial Resistance Biology (CBRB).
NHS using Imperial spinout’s advanced prescription software to improve safety
Imperial spinout Dosium is working with the NHS to roll out a clinical decision support tool that provides dosage guidance to increase patient safety.
2
Drug could boost chemotherapy to treat aggressive brain tumours
Imperial researchers have discovered a drug which could boost the effectiveness of chemotherapy to treat aggressive brain tumours in adults.
Research on environmental risks of pet parasiticides receives President’s Award
An interdisciplinary research group showing the environmental risks of pet parasiticides has received Imperial College London's President's Award.
Department of Chemistry Launches New Postgraduate Course
Nanomedicine and Nanodiagnostics (MRes) is launched to offer students insight into the latest cutting-edge developments in healthcare.
Fleming Initiative featured in National Action Plan on antimicrobial resistance
The Fleming Initiative is named as key to achieving the Government’s ambitions for tackling antimicrobial resistance over the next 5 years.
